Palbociclib is an anti-cancer drug used to treat hormone receptor-positive breast cancer. It works by inhibiting cyclin-dependent kinases, preventing cancer cell proliferation. Palbociclib is effective in managing specific breast cancer types. In summary, it plays a vital role in targeted cancer therapy.
Palbociclib inhibits CDK4/6, blocking cell cycle progression and reducing tumor growth.



